Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for Microvolt T-Wave Alternans (MTWA), effective May 15, 2026. Here's what billing teams need to do.
CMS Microvolt T-Wave Alternans coverage policy has been updated. The Centers for Medicare & Medicaid Services governs MTWA coverage at the national level, and any modification to this policy directly affects cardiac electrophysiology billing across cardiology and electrophysiology practices billing to Medicare. This policy does not list specific CPT or HCPCS codes in the available data — your team should pull the current policy document and cross-reference your charge capture before May 15, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Microvolt T-Wave Alternans (MTWA) |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | 2026-05-15 |
| Impact Level | Medium-High |
| Specialties Affected | Cardiology, Cardiac Electrophysiology, Internal Medicine |
| Key Action | Review MTWA billing guidelines and audit pending claims before May 15, 2026 |
CMS Microvolt T-Wave Alternans Coverage Criteria and Medical Necessity Requirements 2026
MTWA testing measures tiny fluctuations in the T-wave portion of the ECG signal — fluctuations at the microvolt level — to assess a patient's risk of sudden cardiac death. CMS coverage for this test has always been narrow, and that pattern hasn't changed with this modification.
The real issue with MTWA billing under Medicare is medical necessity documentation. CMS requires that the clinical indication be clearly tied to arrhythmia risk stratification. Vague documentation like "cardiac monitoring" or "arrhythmia workup" will not support a covered claim. Your physicians need to document the specific patient profile that justifies MTWA — typically patients with known structural heart disease or reduced ejection fraction being evaluated for ICD candidacy.
Whether MTWA is covered under Medicare has always depended on the patient meeting defined criteria, not just the physician ordering the test. That distinction matters for your billing team. If your practice has been submitting MTWA claims without tight medical necessity documentation, this modification is a prompt to audit your records now, before the May 15, 2026 effective date.
Prior authorization requirements for MTWA under Medicare have historically not applied at the national level — Medicare does not typically require prior authorization for diagnostic tests under a National Coverage Determination. However, your Medicare Administrative Contractor may have a local coverage determination (LCD) that layers additional requirements on top of the national policy. Check with your MAC before assuming the national standard is the only bar to clear.
CMS MTWA Exclusions and Non-Covered Indications
CMS has historically treated MTWA as non-covered or experimental for a broad set of clinical scenarios. The test has a complicated coverage history — CMS first addressed it in a national coverage analysis that found the evidence base insufficient for routine use across a wide patient population.
MTWA is generally not covered for patients without a documented history of structural heart disease or identifiable arrhythmia risk factors. Screening use in low-risk populations — even with a cardiologist's order — does not meet medical necessity under the CMS coverage policy framework. Claims submitted for that use will generate a claim denial.
The test has also faced scrutiny as a replacement for electrophysiology study (EPS) when EPS would otherwise be the appropriate diagnostic tool. CMS does not accept MTWA as an equivalent substitute for EPS in patients where EPS is the standard of care. That distinction shows up in appeals, and it's the kind of thing that's easier to document before the claim is submitted than to argue after a denial.
Coverage Indications at a Glance
Because the available policy data does not include a formal indication-level breakdown with specific codes, the table below reflects the established CMS coverage framework for MTWA based on the policy's clinical context. Confirm each indication against the full policy document at the source URL before billing.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Arrhythmia risk stratification in patients with structural heart disease | Covered (when criteria met) | Not listed in available policy data | Requires strong medical necessity documentation |
| ICD candidacy evaluation with reduced ejection fraction | Covered (when criteria met) | Not listed in available policy data | Document ejection fraction and clinical rationale explicitly |
| Routine cardiac screening in low-risk patients | Not Covered | Not listed in available policy data | Lacks medical necessity; high denial risk |
| Replacement for EPS when EPS is the standard of care | Not Covered | Not listed in available policy data | CMS does not recognize MTWA as EPS equivalent |
| Asymptomatic patients without documented structural disease | Not Covered / Experimental | Not listed in available policy data | Insufficient evidence basis under CMS coverage policy |
CMS Microvolt T-Wave Alternans Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Pull the full policy document before May 15, 2026. The available data for this modification does not include the specific CPT or HCPCS codes listed in the policy. Go to the source — https://app.payerpolicy.org/p/cms/310-v3 — and get the actual code list. Do not bill off memory or prior versions. |
| 2 | Audit your medical necessity documentation now. Run a report of MTWA claims from the past 12 months. For each claim, verify that the documentation explicitly states the structural heart disease diagnosis, the ejection fraction where applicable, and the clinical rationale for risk stratification. If any claims are thin on documentation, work with your physicians to strengthen the records before the effective date hits. |
| 3 | Check your MAC's local coverage determination. National CMS policy sets the floor, not the ceiling. Your Medicare Administrative Contractor may have an LCD that adds documentation requirements, frequency limits, or coverage restrictions specific to your region. Contact your MAC or check their website for any active LCD on MTWA. |
| 4 | Update your charge capture workflow to flag MTWA claims for review. Between now and May 15, 2026, treat every MTWA claim as a pre-submission review item. This is especially important if this policy modification tightened the coverage criteria — which modifications typically do. A flag in your billing system costs you five minutes. A claim denial and appeal cycle costs you hours. |
| 5 | Brief your ordering cardiologists and electrophysiologists on what's changed. Your billing team can't fix documentation problems that start in the exam room. Set up a short meeting with your cardiology group before May 2026. Walk them through what CMS requires for MTWA medical necessity. Show them what a supportable order looks like versus one that will produce a denial. |
| 6 | Talk to your compliance officer if your practice volume is high. If MTWA makes up a meaningful share of your cardiac diagnostic revenue, the risk exposure here is real. Have your compliance officer review the updated policy language and assess whether your current documentation standards meet the new criteria. Don't wait for a claim denial to find out there's a gap. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Microvolt T-Wave Alternans Under This Policy
The available policy data does not list specific CPT, HCPCS, or ICD-10 codes for this modification. This is a critical gap for your billing team.
Do not guess or rely on codes from prior versions of this policy without confirming they still apply. Pull the full policy from the source and cross-reference with your current fee schedule.
Codes to Look Up From the Full Policy Document
| Code Type | What to Confirm |
|---|---|
| CPT | Which CPT code(s) CMS associates with MTWA testing (historically, spectral analysis codes have applied — confirm current status) |
| HCPCS | Whether any HCPCS Level II codes apply, particularly for equipment-related components |
| ICD-10-CM | Which diagnosis codes CMS accepts as supporting medical necessity for MTWA |
The absence of codes in this data does not mean the policy lacks them — it means the data available at publication did not include them. Treat that as a prompt to go get them, not as clearance to bill without verification.
MTWA billing without confirmed code-to-policy alignment is exactly how denials happen. Get the codes from the source document before the May 15, 2026 effective date.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.